National Institute of Allergy and Infectious Diseases
Defense Threat Reduction Agency
US Department of Agriculture
Bill & Melinda Gates Foundation
California Citrus Research Board
Los Alamos National Laboratory Small Business Assistance Program
The National Institutes of Health support Mesa Biotech’s technology development through RO1 and SBIR grant mechanisms.
Bill and Melinda Gates Foundation
Mesa Biotech has established and will continue a close partnership with the Gates Foundation for the development of our platform technology in the field of human disease diagnostics. With research and product development contracts from the Gates Foundation, Mesa Biotech has developed highly simplified systems prioritizing ease of use and low cost of goods. These efforts have been a win-win situation for both parties, with Mesa Biotech reaping the benefits of cost effective simplified designs ideal for commercialization in for-profit CLIA-waived POC markets while the Gates Foundation gains effective disease diagnostics for low income and resource limited settings. More importantly, work with the Gates Foundation provides access to significant and well established resources for clinical testing, for example the Global Network of WHO Collaborating Centres, that Mesa Biotech will leverage to launch Mesa Biotech diagnostic products into the developing world.
Defense Threat Reduction Agency (DTRA)
Mesa Biotech’s DTRA contracts support the development of next generation rapid nucleic acid tests for a wide range of pathogens. These advanced technology development efforts will support the future augmentation of Mesa Biotech’s product line with automated systems offering wireless connectivity.
Los Alamos National Laboratory (LANL)
Mesa Biotech was spun-off from LANL in 2009 and has maintained a strategic collaboration with LANL and its scientists (e.g. the bioinformatics team) and program offices. We will continue our relationship with LANL to further advance our technology development and product development efforts. LANL is a leader in computation biology and bioinformatics with world-class computing resources for nucleic acid sequence analysis. LANL has developed such informatics resources as GenBank as well as influenza and HIV sequence databases. Access to LANL expertise and resources in bioinformatics has been and will continue to be a benefit to the development and refinement of sequence specific reagents for Mesa Biotech’s test development efforts.
US Department of Agriculture
Mesa Biotech has established a strategic collaboration with the USDA Agricultural Research Service (USDA-ARS) and the USDA Animal and Plant Health Inspection Service (USDA-APHIS) for the development and testing of Mesa Biotech’s Citrus Greening diagnostic product as well as for test menu expansion to offer additional agricultural disease and pest tests. The USDA is not only a collaborator in the development and evaluation of these tests but also a potential customer for products emerging from these efforts. This strategic alliance provides access to tightly regulated test samples, subject area experts, and independent testing and evaluation.